- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06634134
Cycling Through the Menstrual Cycle
Hoe Fietst de Vrouwelijke Wielrenner Door Haar Menstruatiecyclus?
Study Overview
Status
Intervention / Treatment
Detailed Description
More and more women are trying to take their menstrual cycle into account when it comes to training effort, planning and performance. This is called menstrual cycle-based periodized training. However, it is still unknown what the exact influence of the different phases of the menstrual cycle is on training and performance. This includes the influence of hormonal fluctuations during the cycle on training capacity, effort load, restorative capacity, motivation to train and perform, daring to take risks and the mental aspects surrounding training and performance. As a result, general advice about cycle-based periodized training cannot be given at this time.
It has been described in the literature that professional-level cyclists regularly have menstrual cycle disorders (ie RED-s). This has short-term health consequences (less rapid recovery, fatigue) and long-term (osteoporosis, increased risk of cardiovascular disease). At a professional level, this knowledge is slowly penetrating. Less is known about the menstrual cycle of amateur athletes and there is also a lack of knowledge about the effects of the menstrual cycle on performance (endurance capacity, heart rate zones, power achieved).
To gain more insight into the menstrual cycle, the influence of the cycle on training and performance and the influence of training on the cycle of the sporting woman, the aim of this study is to monitor the menstrual cycle of female cyclists in combination with their subjective and objective training parameters. This allows us to create insight and, if useful, adapt training on an individual basis to the phase of the menstrual cycle.
The aim of this research is to investigate how the cyclists' menstrual cycle progresses and whether the cycle has an effect on performance.
Study Type
Enrollment (Estimated)
Contacts and Locations
Study Contact
- Name: Anne Marijn van der Graaf, MD/PhD
- Phone Number: 0031611474158
- Email: annemarijn.graaf@outlook.com
Study Contact Backup
- Name: Margot Verleg
- Phone Number: 0031505246078
- Email: m.verleg@mzh.nl
Study Locations
-
-
-
Groningen, Netherlands, 9728 NZ
- Not yet recruiting
- Martini Ziekenhuis
-
Contact:
- Anne Marijn van der Graaf, MD/PhD
- Phone Number: 0031611474158
- Email: annemarijn.graaf@outlook.com
-
Sub-Investigator:
- Emma Paternotte, MD
-
Sub-Investigator:
- Frederieke Siemens, MD/PhD
-
Sub-Investigator:
- Merel Wielink, MD
-
Sub-Investigator:
- Pamela Schedelaar, MD/PhD
-
Groningen, Netherlands, 9728 NZ
- Recruiting
- Martini Ziekenhuis
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
Accepts Healthy Volunteers
Sampling Method
Study Population
Description
Inclusion Criteria:
- JOIN cycling app member
- female cyclist
- informed consent period tracking in JOIN
Exclusion Criteria:
- none
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Female cyclist
All female cyclist that consent using the data collected by JOIN cycling app and also give permission tracking thier menstrual cycle. Natrual menstrual cycle. Hormonal contraceptive use Intra-uterine device use (hormonal vs non-hormonal) |
Based on discomfort related to the menstrual cycle the female cyclist can choose to adjust the suggested training.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Health of menstrual cycle in amateur cyclist
Time Frame: 1 year
|
It is known that the incidence of amenorrhea is about 15% of the professional female athletes.
This has many short- and long term health consequences.
These health consequences can be avoided since developing amenorrhea is preventable.
It is unknown how many amateur cyclist have an irregular period or have amenorrhea.
Insight in the size of this health problem creates a window of opportunity in preventive medicine.
|
1 year
|
|
Objective training parameters during the menstral cycle
Time Frame: 2 years
|
By collecting details in regards to the menstrual cycle in combination with objective parameters (heart rate, power, speed, endurance) of training it is possible to investigate whether these objective parameters are influenced by the hormonal fluctuations during the menstrual cycle.
|
2 years
|
|
Subjective training parameters during the menstrual cycle
Time Frame: 2 years
|
By collecting details in regards to the menstrual cycle in combination with subjective parameters (fatigue, discomfort, readiness, motivation) of training it is possible to investigate whether these subjective parameters are influenced by the hormonal fluctuations during the menstrual cycle.
|
2 years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Is menstrual cycle-based periodized training feasible in the future?
Time Frame: 2 years
|
In case the menstrual cycle affects objective and subject training parameters, it might be feasible to adjust the training program based on the phase of the menstrual cycle.
|
2 years
|
|
Does the menstrual cycle affect recovery?
Time Frame: 2 years
|
Improving endurance, muscle strength and power is not only training, but also the quality of recovery.
Therefore, it is interesting to investigate whether the hormonal changes during the menstrual cycle affect recovery (i.e.
readiness).
|
2 years
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Questionnaires
Time Frame: 3 years
|
Out of the complete cohort included, it is possible to select a specific group of cyclist to dive deeper into menstrual cycle related training parameters
|
3 years
|
|
Excercise testing
Time Frame: 3 years
|
Out of the complete cohort included, it is possible to select a specific group of cyclist who can be invited to perform excercise tests during different moments of the menstrual cycle.
|
3 years
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- MenstrualCycling
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.